Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies
Current Issues in Molecular Biology · 17.04.2025 · 47 (4) · 287
DOI: 10.3390/cimb47040287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 17.04.2025. Verfasst von Milena Kostadinova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Immunology of Reproduction, Department of Molecular Immunology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FNI-Bulgaria; InfraACT, FNI-Bulgaria, InfraACT.
Abstract (Originalsprache)
Bone tissue engineering (BTE) has emerged as a promising strategy for addressing bone defects and disorders that cannot be repaired through traditional methods. This field leverages the potential of various biomaterials, cells, and bioactive factors to promote bone regeneration. Mesenchymal stem cells (MSCs) have gained significant attention due to their osteogenic potential, which can be enhanced through osteoinductive factors. Osteoinductive factors, including growth factors like BMPs, TGF-β, VEGF, and IGF, play a crucial role in stimulating the osteodifferentiation process, thereby promoting bone regeneration. Furthermore, bioprinting technologies have opened new avenues for precisely designing scaffolds that can mimic the native bone architecture and provide a conducive environment for MSC differentiation. The integration of bioprinting with mesenchymal stem cells and osteoinductive factors has the potential to revolutionize regenerative therapies by allowing for the creation of patient-specific bone grafts. This review highlights the latest developments in MSC-based therapies, the role of osteoinductive factors, and the impact of bioprinting in advancing BTE. It also discusses future directions for improving the efficacy and clinical translation of these technologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biology and Immunology of Reproduction, Department of Molecular Immunology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Institute of Information and Communication Technologies, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Department of Orthopedics and Traumatology, University Hospital Queen Giovanna-ISUL, 1527 Sofia, Bulgaria.
ORCID-Profile: Milena Kostadinova, Miryana Raykovska, Radoil Simeonov, Stephan Lolov, Milena Mourdjeva
Förderung
- FNI-Bulgaria; InfraACT
- FNI-Bulgaria
- InfraACT
- National Roadmap
Zitieren
APA
Kostadinova, M., Raykovska, M., Simeonov, R., Lolov, S., & Mourdjeva, M. (2025). Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies. Current Issues in Molecular Biology, 47(4), 287. https://doi.org/10.3390/cimb47040287
Vancouver
Kostadinova M, Raykovska M, Simeonov R, Lolov S, Mourdjeva M. Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies. Current Issues in Molecular Biology. 2025;47(4):287. doi:10.3390/cimb47040287
BibTeX
@article{Kostadinova2025,
author = {Kostadinova, Milena and Raykovska, Miryana and Simeonov, Radoil and Lolov, Stephan and Mourdjeva, Milena},
title = {Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {4},
pages = {287},
doi = {10.3390/cimb47040287}
}
EUVIMED